Concepedia

Jeffrey Weidlick

JW

Statistics

Publications

7

Citations

359

H-Index

7

Active since

2007

Affiliations

Celldex Therapeutics (United States)(Current)

Jeffrey Weidlick is an author at Celldex Therapeutics (United States) specializing in immunology, cancer immunology, and cancer immunotherapy.

Publications per year

2007–2020

7

Publications

7

Agonist Anti-Human CD27 Monoclonal Antibody Induces T Cell Activation and Tumor Immunity in Human CD27–Transgenic Mice

Li-Zhen He, Naseem Prostak, Lawrence J. Thomas et al. · The Journal of Immunology · 2013 · 102 citations

, , +17

Development of a Human Monoclonal Antibody for Potential Therapy of CD27-Expressing Lymphoma and Leukemia

Laura Vitale, Li-Zhen He, Lawrence J. Thomas et al. · Clinical Cancer Research · 2012 · 68 citations

, , +17

Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy

Laura Vitale, Lawrence J. Thomas, Li-Zhen He et al. · Cancer Immunology Immunotherapy · 2018 · 67 citations · Full text

, , +12

An extensive phenotypic characterization of the hTNFα transgenic mice

Michael D. Hayward, Beverly K. Jones, Arman Saparov et al. · BMC Physiology · 2007 · 57 citations · Full text

, , +17

Development of CDX-527: a bispecific antibody combining PD-1 blockade and CD27 costimulation for cancer immunotherapy

Laura Vitale, Li-Zhen He, Lawrence J. Thomas et al. · Cancer Immunology Immunotherapy · 2020 · 29 citations · Full text

, , +17

1–5 of 7